logo
Plus   Neg
Share
Email

Stock Alert: Tenax Surges 60% On Positive Data From Levosimendan Trial

Shares of Tenax Therapeutics, Inc. (TENX) soared over 60% on Tuesday morning after the pharma maker reported positive data from mid-stage trial of levosimendan for treatment in heart disorder.

TENX is currently trading at $2.36, up $0.91 or 62.76%, on the Nasdaq.

Tenax announced positive Phase 2 results for levosimendan to reat pulmonary hypertension and heart failure with preserved ejection fraction.

Levosimendan demonstrated a statistically significant reduction in pulmonary capillary wedge pressure, the primary efficacy analysis, compared to baseline and placebo when the measurements at rest, with legs up and on exercise were combined. Levosimendan also showed significant improvement in 6-minute walk distance compared to placebo.

While there was no significant change in pulmonary capillary wedge pressure during exercise, patients had reductions from baseline at Week 6 in pulmonary artery pressure and right atrial pressure.

Dr. Stuart Rich, Professor of Medicine at the Bluhm Cardiovascular Institute at Northwestern University commented "Levosimendan is the first drug to ever show a favorable mechanism of action with biventricular effects in patients with PH-HFpEF. The consistency of the hemodynamic data and improvement in 6-minute walk demonstrates that levosimendan has great promise as a treatment for PH-HFpEF which has a serious unmet need. The favorable safety profile, especially the absence of any proarrhythmic effects, supports the further development with a phase 3 trial."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Kader Exports pvt. Ltd. is recalling certain consignments of various frozen cooked shrimp citing potential contamination with Salmonella, according to the U.S. Food and Drug Administration. The affected frozen cooked, peeled and deveined shrimp products were sold in 1lb, 1.5lb., and 2lb. retail bags. They were distributed from late February 2020 to Mid-May 2020 across the nation. The former chief executive officer of Hertz Global Holdings, Mark Frissora, agreed to pay about $2.2 million to settle the U.S. Securities and Exchange Commission's claims that he played a key role in causing the now-bankrupt car-rental company to file inaccurate financial statements in 2013. Daimler AG, the maker of Mercedes-Benz cars, said Thursday that it has agreed to pay more than $2.2 billion to settle U.S. claims over emissions from its diesel vehicles.
Follow RTT